Глобальный рынок неионизирующей визуализации молочной железы – тенденции отрасли и прогноз до 2029 года

Анализ и размер мирового рынка неионизирующих методов визуализации молочной железы

По данным Всемирной организации здравоохранения (ВОЗ), рак груди является вторым по распространенности видом рака среди женщин, и ежегодно в мире диагностируется более 200 000 новых случаев рака. Рост заболеваемости раком груди еще больше повысил осведомленность о ранней диагностике рака груди во всем мире. В результате поддерживающие государственные инициативы способствуют распространению информации о факторах риска рака, профилактических мерах и ранней диагностике. Следовательно, эти факторы роста будут способствовать расширению рынка в прогнозируемый период.

• Рынок неионизирующей визуализации молочной железы был оценен в 4,02 млрд долларов США в 2021 году и, как ожидается, достигнет 7,77 млрд долларов США к 2029 году, регистрируя среднегодовой темп роста 8,60% в 2022-2029 годах. «Ультразвуковое исследование молочной железы» составляет самый большой сегмент на рынке неионизирующей визуализации молочной железы в прогнозируемый период из-за более низкого риска воздействия радиации и различных преимуществ, таких как способность обнаруживать поражения и способность различать кисту и твердую массу, а также обнаружение кровотока по сосудам. Отчет о рынке, подготовленный командой Data Bridge Market Research, включает в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативную базу.

Определение мирового рынка неионизирующих методов визуализации молочной железы

Визуализация груди — это диагностическая радиологическая субспециализация, которая включает в себя визуализацию груди в диагностических или скрининговых целях. Технологии визуализации груди используются для изучения тканей женской груди с целью диагностики рака груди и других заболеваний, связанных с грудью. Некоторые из самых популярных обследований визуализации груди включают маммографию, магнитно-резонансную томографию груди (МРТ) и ультразвук.

Область отчета и сегментация рынка

Non-Ionizing Breast Imaging Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Growing Requirement for Diagnosis

The rising prevalence of breast cancer is the most significant factor driving the growth for this market as it further requires diagnosis and screening. The increasing population of women who are more susceptible to breast cancer is also projected to bolster the market's growth.

Furthermore, the expanding healthcare sector along with the rise in demand for early diagnosis are also expected to fuel market growth. Moreover, the increasing number of screening programs, as well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis, also cushions the market's growth within the forecasted period.

Opportunities

• Improving Reimbursement, Funding and Investments

Moreover, the improving reimbursement scenario and increase in funding from private and government organizations for the development of healthcare infrastructure are estimated to generate lucrative opportunities for the market. The growing government and private investments to meet the increasing demand for breast cancer screening will further offer numerous growth opportunities for the market.

Restraints/Challenges Global Non-Ionizing Breast Imaging Market

• High Costs

On the other hand, the high cost required for detecting breast cancer is expected to obstruct market growth.

• Effects of Radiation

The adverse effects from exposure to radiation leads to the lesser population turn up for the procedure. This factor is estimated to impede the overall growth of the market.

• Strict Regulations

Also, the stringent regulatory approval procedures are projected to challenge the non-ionizing breast imaging market in the forecast period of 2022-2029.

This non-ionizing breast imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the non-ionizing breast imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Non-Ionizing Breast Imaging Market

The emergence of COVID-19 pandemic put a strain on healthcare systems all around the world. The non-ionizing breast imaging market was largely impacted by the outbreak of COVID-19.

During the pandemic, the imposition of the lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, led to halt of various operations, supply chain disruptions, stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales further limits the industry's expansion. The implementation of lockdown resulted in a decrease in the number of patient visits for other diseases such as cancer and diabetes. According to the Eurasian Journal of Medical Investigation (EJMI), between April and July 2020, there was a 41.7 percent -64.4 percent reduction in the number of breast imaging modalities. The mammography technology showed the most significant decline. The mammography technology showed the most significant decline.

Recent Developments

• In April 2021, Seno Medical's Imagio P200003 Breast Imaging System has been authorized by the US Food and Drug Administration (FDA). The Imagio Breast Imaging System images breast tissues using both optoacoustic (OA) and ultrasound (US) technology to assist clinicians in examining breast abnormalities.
• In April 2021, Dilon Technologies Inc., the owner of the Navigator Gamma Probes and a world-class global leader in breast cancer therapy and detection, has acquired all of Dune Medical's assets, including Dune Medical's "MarginProbe essentially."

Global Non-Ionizing Breast Imaging Market Scope

The non-ionizing breast imaging market is segmented on the basis of type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Breast Ultrasound
• Breast MRI
• Automated Whole-breast Ultrasound (AWBU)
• Breast thermography
• Electric Impedance Tomography
• Optical Imaging

On the basis of type, the non-ionizing breast imaging market is segmented into breast ultrasound, breast MRI, automated whole-breast ultrasound (AWBU), breast thermography, electric impedance tomography and optical imaging. The breast ultrasound segment is projected to account for the largest share owing to the lower risk of exposure to radiation and the various benefits such as the ability to detect lesions and the ability to differentiate between a cyst and a solid mass and the detection of blood flow through vessels.

End User

• Hospital
• Diagnostic Imaging Centre
• Others

On the basis of end user, the non-ionizing breast imaging market is bifurcated into hospital, diagnostic imaging centre and others.

Non-Ionizing Breast Imaging Market Regional Analysis/Insights

The non-ionizing breast imaging market is analyzed and market size insights and trends are provided by country, type and end user as referenced above.

The countries covered in the non-ionizing breast imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the non-ionizing breast imaging market because of the substantial research and development expenditure, well-established healthcare infrastructures, widespread acceptance of advanced medical technologies and superior reimbursement facilities within the region.

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rising government and non-government initiatives to prevent breast cancer coupled with the constant development in the healthcare infrastructures within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The non-ionizing breast imaging market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for non-ionizing breast imaging market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the non-ionizing breast imaging market. The data is available for historic period 2010-2020.

Competitive Landscape and Non-Ionizing Breast Imaging Market Share Analysis

The non-ionizing breast imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to non-ionizing breast imaging market.

Some of the major players operating in the non-ionizing breast imaging market are

• Hologic, Inc. (U.S.)
• General Electric (U.S.)
• Siemens (Germany)
• Koninklijke Philips N.V. (Netherlands)
• Fujifilm Holdings Corporation (Japan)
• Canon Inc. (Japan)
• Aurora Healthcare US Corp. (U.S.)
• Allengers (India)
• Dilon Medical Technologies, Inc. (U.S.)
• Siemens (Germany)
• Planmed Oy. (Finland)
• Delphinus Medical Technologies, Inc. (U.S.)
• Micrima Limited (U.K)
• CMR Naviscan Corporation (U.S.), SuperSonic Imagine (France)
• Carestream Health (U.S.)

Research Methodology : Global Non-Ionizing Breast Imaging Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Помимо этого, модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор и руководство рынка, сетку позиционирования компании, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами  https://www.databridgemarketresearch.com/ru/speak-to-analyst/?dbmr=global-non-ionizing-breast-imaging-market

SKU-67991